Board of Directors
The Lundquist Institute Board of Directors plays a pivotal role in guiding the Institute’s strategic direction, ensuring fiscal responsibility, and fostering a culture of excellence.
Joseph Berenato | Chair
Former Chairman and CEO, Ducommun Inc.
Eric Daar, MD* | Vice Chair
Executive Medical Officer, The Lundquist Institute
Chief, Division of HIV Medicine, Harbor-UCLA Medical Center
Laura Survant | Vice Chair
Partner, Deloitte & Touche LLP
Delphine Lee, MD, PhD* | Secretary
Executive Director, Infectious Diseases & Immunology Innovation Hub, The Lundquist Institute
Chief of Dermatology and Residency Program Director, Harbor-UCLA Medical Center
Tom Anastassiou | Treasurer
Managing Member, Paseo Capital Management LLC
Denise Al Alam, PhD*
Executive Resource Integration Officer, The Lundquist Institute
Kelly Callahan, MD, MPT*
Interim Chair, Department of Pediatrics, Harbor-UCLA Medical Center
Christian de Virgilio, MD*
Chair, Department of Surgery, Harbor-UCLA Medical Center
Andrew Foster
Partner, Boston Consulting Group
Griselda Gutierrez, MD
Chief Medical Officer, Harbor-UCLA Medical Center
Elliot Hinds
Partner, Sheppard
Christopher Lee, MD
Vice President of Pharmaceuticals and Biotechnology, Capital Group
Melanie Lundquist
Philanthropist
Richard Lundquist
President and CEO, Continental Development Corporation
Paul Mathews, PhD*
Executive Director, Advanced Therapeutics & Biomedical Technologies Innovation Hub, The Lundquist Institute
Loren Miller, MD, MPH*
Executive Community Engagement Officer, The Lundquist Institute
Chief, Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center
Steven A. Nissen
President and CEO, Nissen Consulting Group
Thomas A. Parham, PhD
President Emeritus, CSU Dominguez Hills
Joe W. Ramos, PhD
President and CEO, The Lundquist Institute
Mitchel Sayare, PhD
Chairman, Altimmune Inc.
Joseph Thomas, MD*
Chair, Department of Medicine, Harbor-UCLA Medical Center
*Principal Investigator, The Lundquist Institute